title: Characterization of the TSU-PR1 cell line by chromosome painting and flow cytometry.
abstract: TSU-PR1 was originally reported as a prostatic carcinoma cell line derived from a lymph node metastasis. Recently, however, this cell line was reported to be derived from T24 bladder carcinoma cells, and thus further definition of its origin is needed. Conventional cytogenetic study of TSU-PR1 showed aneuploidy, ranging from 65 to 86 chromosome with a modal number of 80, and with 10 marker chromosomes, thus conventional cytogenetics cannot be used to determine which chromosomes or regions of chromosomes are critical in cancer development and progression of this cell line. The present study was conducted to characterize genetic changes of the cell line using comparative genomic hybridization (CGH), fluorescence in situ hybridization (FISH), and flow cytometry. CGH results showed that green-to-red fluorescence ratios were within the range of 0.85-1.15, except for a few chromosomes, which reflected near tetraploidy in TSU-PR1. Flow cytometric analysis of TSU-PR1 revealed a DNA index of 3.46n, which is close to the 3.48n calculated from a modal number of 80. The copy numbers of chromosomes 4, 6, 7, 17, and 20 determined by the DNA index and the CGH analyses were 2.85 +/- 0.09, 3.22 +/- 0.77, 3.01 +/- 0.26, 4.05 +/- 0.44, and 4.99 +/- 0.48, respectively. These numbers are also in accordance with the chromosome copy numbers determined with FISH: 2.98 +/- 0.23, 2.91 +/- 0.44, 2.74 +/- 0.44, 3.93 +/- 0.38, and 5.05 +/- 0.78 for chromosomes 4, 6, 7, 17, and 20, respectively (P > 0.05).
authors.affiliation: Dental Science Research Institute, Department of Oral Anatomy, School of Dentistry, Chonnam National University, Yongbongdong, Gwangju 500-757, Republic of Korea.
authors.forename: M S
authors.initials: MS
authors.lastname: Kim
authors.forename: S H
authors.initials: SH
authors.lastname: Kim
authors.forename: H J
authors.initials: HJ
authors.lastname: Kim
authors.forename: I N
authors.initials: IN
authors.lastname: Hoang
authors.forename: W M
authors.initials: WM
authors.lastname: Oh
authors.forename: J T
authors.initials: JT
authors.lastname: Koh
authors.forename: H O
authors.initials: HO
authors.lastname: Park
authors.forename: J Y
authors.initials: JY
authors.lastname: Jeong
authors.forename: W J
authors.initials: WJ
authors.lastname: Kim
authors.forename: E J
authors.initials: EJ
authors.lastname: Lee
authors.forename: J Y
authors.initials: JY
authors.lastname: Koh
authors.forename: B Y
authors.initials: BY
authors.lastname: Kim
authors.forename: R H
authors.initials: RH
authors.lastname: Jensen
mesh_terms: D002277:Carcinoma / Q000235:genetics; D045744:Cell Line, Tumor; D002874:Chromosome Mapping; D020223:Chromosome Painting / Q000379:methods*; D005434:Flow Cytometry / Q000379:methods; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D008214:Lymphocytes / Q000166:cytology / Q000473:pathology; D008297:Male; D008677:Metaphase; D009693:Nucleic Acid Hybridization; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000473:pathology